Chemical inhibitors of Neurexophilin-4 target various aspects of the synaptic transmission process in which this protein is involved. Tetrodotoxin, a well-known marine toxin, can block voltage-gated sodium channels, which are crucial for the generation and propagation of neuronal action potentials. By inhibiting these channels, tetrodotoxin can attenuate synaptic signaling, leading to a reduction in the functional activity of Neurexophilin-4, which is closely associated with synaptic interactions. Similarly, ω-Conotoxin GVIA and ω-Agatoxin IVA can selectively inhibit N-type and P/Q-type calcium channels, respectively. Since calcium influx is vital for the release of neurotransmitters into the synaptic cleft, blocking these channels can directly diminish the synaptic activity where Neurexophilin-4 is active, thus functionally inhibiting its role.
On the other hand, Bafilomycin A1, Concanamycin A, and Botulinum toxin A target the mechanisms underlying the storage and release of neurotransmitters. Bafilomycin A1 and Concanamycin A inhibit the H+-ATPase pump responsible for the acidification of synaptic vesicles, which is a prerequisite for neurotransmitter loading. This inhibition can hamper synaptic transmission, affecting the functional participation of Neurexophilin-4 in these processes. Botulinum toxin A disrupts the SNARE complex formation, an essential step in vesicle fusion and neurotransmitter release, thereby functionally inhibiting the role of Neurexophilin-4 in synaptic vesicle dynamics. Vesamicol takes a similar approach by inhibiting the vesicular acetylcholine transporter, which is critical for acetylcholine storage in vesicles. Additionally, Latrunculin A and Colchicine disrupt the cytoskeletal elements necessary for vesicle trafficking. Latrunculin A destabilizes actin filaments while Colchicine binds to tubulin, inhibiting microtubule polymerization crucial for vesicle transport, thus impeding the synaptic processes where Neurexophilin-4 is involved. Lastly, Nifedipine and ω-Conotoxin MVIIC block L-type and Q/N-type calcium channels, respectively, decreasing calcium-dependent neurotransmitter release, while Dynasore inhibits the dynamin-mediated endocytosis necessary for vesicle recycling. All these mechanisms collectively contribute to the functional inhibition of Neurexophilin-4 by impeding various steps of the synaptic transmission pathway in which it is involved.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ω-Agatoxin IVA | 145017-83-0 | sc-302015 | 100 µg | $463.00 | ||
Specifically blocks P/Q-type calcium channels, which are important for neurotransmitter release in certain synaptic pathways. Inhibition of these channels can reduce the synaptic activity associated with Neurexophilin-4. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Inhibits the vacuolar type H+-ATPase (V-ATPase), which is crucial for neurotransmitter loading into synaptic vesicles. This inhibition can decrease neurotransmitter release where Neurexophilin-4 may be active. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
Inhibits V-ATPase like Bafilomycin A1, impairing acidification of synaptic vesicles and neurotransmitter loading, thereby affecting the synaptic processes involving Neurexophilin-4. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Disrupts actin polymerization which is critical for synaptic vesicle trafficking. This can lead to impaired synaptic function where Neurexophilin-4 is implicated. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Binds to tubulin and inhibits its polymerization, affecting microtubule dynamics which are essential for neurotransmitter vesicle transport, potentially inhibiting processes involving Neurexophilin-4. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Blocks L-type calcium channels, subsequently reducing calcium influx that is necessary for neurotransmitter release at the synapse, which may inhibit Neurexophilin-4 function. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Non-competitive inhibitor of dynamin, a GTPase required for endocytosis of synaptic vesicles, thus potentially inhibiting the synaptic recycling where Neurexophilin-4 is active. | ||||||